miércoles, 17 de agosto de 2022

Efficacy and safety of the investigational complement C5 inhibitor zilucoplan in patients hospitalized with COVID-19: an open-label randomized controlled trial | Respiratory Research | Full Text

Efficacy and safety of the investigational complement C5 inhibitor zilucoplan in patients hospitalized with COVID-19: an open-label randomized controlled trial | Respiratory Research | Full Text

No hay comentarios:

Publicar un comentario